Homocysteine and vascular diseases.
Marasini
Bianca
B
Massarotti
Marco
M
Biondi
Maria Luisa
ML
D000527:Alprostadil / Q000008:administration & dosage / Q000031:analogs & derivatives*; D003505:Cyclodextrins / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005492:Folic Acid / Q000187:drug effects; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D007262:Infusions, Intravenous; D011928:Raynaud Disease / Q000097:blood / Q000150:complications / Q000188:drug therapy; D012595:Scleroderma, Systemic / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D047391:alpha-Cyclodextrins; D014841:von Willebrand Factor / Q000032:analysis
D003505:Cyclodextrins; D047391:alpha-Cyclodextrins; C043214:prostaglandin E1-alpha-cyclodextrin; D014841:von Willebrand Factor; D006710:Homocysteine; D005492:Folic Acid; D000527:Alprostadil